Literature DB >> 26063862

Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.

Hao Li1, Masood ur Rehman Kayani2, Yunting Gu3, Xiaobo Wang3, Ting Zhu2, Hongfei Duan4, Yifeng Ma3, Hairong Huang5, Babak Javid6.   

Abstract

Drug resistance to tuberculosis remains a major public health threat. Here, we report two cases of extended-spectrum extensively drug-resistant (XXDR) tuberculosis showing resistance to most first- and second-line agents. The results of a correlation of whole-genome sequencing (WGS) and phenotypic testing were discordant, suggesting that overreliance on WGS may miss clinically relevant resistance in extensively drug-resistant disease.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26063862      PMCID： PMC4508398          DOI： 10.1128/JCM.00891-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Totally drug-resistant tuberculosis in India.

Authors:  Zarir F Udwadia; Rohit A Amale; Kanchan K Ajbani; Camilla Rodrigues
Journal:  Clin Infect Dis       Date:  2011-12-21       Impact factor: 9.079

2.  New insight into extremely drug-resistant tuberculosis: using atomic force microscopy.

Authors:  A A Velayati; P Farnia; M A Merza; G K Zhavnerko; P Tabarsi; L P Titov; J Ghanavei; P Farnia; M Setare; N N Poleschuyk; P Owlia; M Sheikolslami; R Ranjbar; M R Masjedi
Journal:  Eur Respir J       Date:  2010-12       Impact factor: 16.671

3.  125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

Authors:  G B Migliori; R Loddenkemper; F Blasi; M C Raviglione
Journal:  Eur Respir J       Date:  2007-03       Impact factor: 16.671

Review 4.  Fitness cost of drug resistance in Mycobacterium tuberculosis.

Authors:  S Gagneux
Journal:  Clin Microbiol Infect       Date:  2009-01       Impact factor: 8.067

5.  First tuberculosis cases in Italy resistant to all tested drugs.

Authors:  G B Migliori; G De Iaco; G Besozzi; R Centis; D M Cirillo
Journal:  Euro Surveill       Date:  2007-05-17

Review 6.  Novel diagnostics and therapeutics for drug-resistant tuberculosis.

Authors:  Melody Toosky; Babak Javid
Journal:  Br Med Bull       Date:  2014-05-08       Impact factor: 4.291

7.  Microevolution of extensively drug-resistant tuberculosis in Russia.

Authors:  Nicola Casali; Vladyslav Nikolayevskyy; Yanina Balabanova; Olga Ignatyeva; Irina Kontsevaya; Simon R Harris; Stephen D Bentley; Julian Parkhill; Sergey Nejentsev; Sven E Hoffner; Rolf D Horstmann; Timothy Brown; Francis Drobniewski
Journal:  Genome Res       Date:  2012-01-31       Impact factor: 9.043

8.  Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.

Authors:  Soumitesh Chakravorty; Jong Seok Lee; Eun Jin Cho; Sandy S Roh; Laura E Smith; Jiim Lee; Cheon Tae Kim; Laura E Via; Sang-Nae Cho; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2014-10-22       Impact factor: 5.948

9.  Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.

Authors:  Z Zhang; M Liu; Y Wang; Y Pang; K M Kam; Y Zhao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-07       Impact factor: 3.267

10.  High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.

Authors:  Levan Jugheli; Nino Bzekalava; Pim de Rijk; Krista Fissette; Françoise Portaels; Leen Rigouts
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191
View more
  4 in total

1.  Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.

Authors:  Garrett C Moraski; Ryan Bristol; Natalie Seeger; Helena I Boshoff; Patricia Siu-Yee Tsang; Marvin J Miller
Journal:  ChemMedChem       Date:  2017-06-27       Impact factor: 3.466

2.  Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to para-Aminosalicylic Acid in Mycobacterium tuberculosis.

Authors:  Ji-Fang Yu; Jin-Tian Xu; Shan-Shan Yang; Mei-Na Gao; Hao-Rui Si; Dong-Yan Xiong; Jing Gu; Zhi-Long Wu; Jie Zhou; Jiao-Yu Deng
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.191

3.  Whole-Genome Sequence of a Beijing Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolate from Buenaventura, Colombia.

Authors:  N Alvarez; D Haft; U A Hurtado; J Robledo; F Rouzaud
Journal:  Genome Announc       Date:  2016-01-14

4.  Whole-Genome Sequencing of Two Latin American-Mediterranean Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Medellín, Colombia.

Authors:  N Alvarez; D Haft; U A Hurtado; J Robledo; F Rouzaud
Journal:  Genome Announc       Date:  2016-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.